REQUEST A DEMO
Total
USD $0.00
Search more companies

Y.S.P. Southeast Asia Holding Berhad (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Y.S.P. Southeast Asia Holding Berhad Profile Updated: February 27, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Y.S.P. Southeast Asia Holding Berhad produces and trades pharmaceuticals and healthcare products. The products comprise of tablets, capsules, suppositories, ointments, creams, powders and syrups. The production plants are situated on 3 acres of land, which is located at Bandar Baru Bangi, Kajang. The products are exported to Singapore, Vietnam and Philippines. The company was incorporated in 2001 and is based in Kuala Lumpur.

Legal Address
Level 22, Menara Lgb,No. 1, Jalan Wan Kadir,Taman Tun Dr. Ismail
Kuala Lumpur; Federal Territories; Postal Code: 60000

Contact Details: Purchase the Y.S.P. Southeast Asia Holding Berhad report to view the information.

Website: http://www.yspsah.com

Basic Information
Total Employees:
Purchase the Y.S.P. Southeast Asia Holding Berhad report to view the information.
Outstanding Shares:
Purchase the Y.S.P. Southeast Asia Holding Berhad report to view the information.
Financial Auditors:
Purchase the Y.S.P. Southeast Asia Holding Berhad report to view the information.
Incorporation Date:
October 07, 2001
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
10.53%
Subsidiaries
Kumpulan Y.S.P. (Malaysia) Sdn. Bhd.
100%
Y.S.P. (Cambodia) Pte. Ltd. (Cambodia)
100%
Y.S.P. Industries (M) Sdn. Bhd.
100%
Company Performance
Financial values in the chart are available after Y.S.P. Southeast Asia Holding Berhad report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
21.02%
Total operating revenue
20.62%
Operating profit (EBIT)
176.55%
EBITDA
88.49%
Net Profit (Loss) for the Period
153.04%
Total assets
4.21%
Total equity
6.15%
Operating Profit Margin (ROS)
7.72%
Net Profit Margin
6.07%
Return on Equity (ROE)
4.61%
Debt to Equity Ratio
-5.48%
Quick Ratio
0.25%
Cash Ratio
0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?